Evidence map›Paper›PMID 23042265›Full record

ArticleFolia histochemica et cytobiologica2012

Inverse relationship between TCTP/RhoA and p53 /cyclin A/actin expression in ovarian cancer cells.

Malgorzata Kloc, Neelam Tejpal, Jitinderpal Sidhu, Malathesha Ganachari, Pedro Flores-Villanueva, Nicholas B Jennings, Anil K Sood, Jacek Z Kubiak, Rafik M Ghobrial

Open access · goldAbstract read
In one paragraph

Article in Folia histochemica et cytobiologica, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Malgorzata KlocDepartment of Surgery, The Methodist Hospital, Houston, TX 77030, USA.
Neelam Tejpal
Jitinderpal Sidhu
Malathesha Ganachari
Pedro Flores-Villanueva
Nicholas B Jennings
Anil K Sood
Jacek Z Kubiak
Rafik M Ghobrial
Houston Methodist · USThe University of Texas MD Anderson Cancer Center · USCentre National de la Recherche Scientifique · FRMethodist Hospital · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UNIVERSITY OF TEXAS MD ANDERSON SPORE IN OVARIAN CANCERP50CA083639 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BAST, ROBERT C · 1999 to 2015
$33.0M
NCI NIH HHS CA16672NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA083639
6 · The paper itself

Abstract

The translationally controlled tumor protein (TCTP) plays a role in cell growth, cell cycle and cancer progression. TCTP controls negatively the stability of the p53 tumor suppressor protein and interacts with the cellular cytoskeleton. The deregulation of the actin and cytokeratin cytoskeleton is responsible for the increased migratory activity of tumor cells and is linked with poor patient outcome. Recent studies indicate that cyclin A,a key regulator of cell cycle, controls actin organization and negatively regulates cell motility via regulation of RhoA expression. We studied the organization of actin and cytokeratin cytoskeleton and the expression of TCTP, p53,cyclin A, RhoA and actin in HIO180 non-transformed ovarian epithelial cells, and OVCAR3 and SKOV3 (expressing low level of inducible p53) ovarian epithelial cancer cells with different metastatic potential. Immunostaining and ultrastructural analyses illustrated a dramatic difference in the organization of the cytokeratin and actin filaments in non-transformed versus cancer cell lines. We also determined that there is an inverse relationship between the level of TCTP/RhoA and actin/p53/cyclin A expression in ovarian cancer cell lines. This previously unidentified negative relationship between TCTP/RhoA and actin/p53/cyclin A may suggest that this interaction is linked with the high aggressiveness of ovarian cancers.

Indexed as

Gene Expression Regulation, NeoplasticActinsBiomarkers, TumorBlotting, WesternCell Line, TumorCyclin A1FemaleHumansKeratinsOvarian NeoplasmsProtein TransportrhoA GTP-Binding ProteinTumor Protein, Translationally-Controlled 1Tumor Suppressor Protein p53ActinsBiomarkers, TumorCCNA1 protein, humanCyclin A1KeratinsrhoA GTP-Binding ProteinRHOA protein, humanTPT1 protein, humanTumor Protein, Translationally-Controlled 1Tumor Suppressor Protein p53

Identifiers

PMID23042265
PMCPMC3753092
OpenAlexW2143824937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.